Pfizer Inc (PFE)
40.39
+0.21 (+0.52%)
USD |
NYSE |
Mar 24, 16:00
40.45
+0.06 (+0.15%)
After-Hours: 20:00
Pfizer Cash and Short Term Investments (Quarterly): 22.73B for Dec. 31, 2022
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2022 | 22.73B |
| September 30, 2022 | 36.12B |
| June 30, 2022 | 33.30B |
| March 31, 2022 | 23.90B |
| December 31, 2021 | 31.07B |
| September 30, 2021 | 29.70B |
| June 30, 2021 | 21.70B |
| March 31, 2021 | 13.67B |
| December 31, 2020 | 12.22B |
| September 30, 2020 | 10.50B |
| June 30, 2020 | 11.38B |
| March 31, 2020 | 10.35B |
| December 31, 2019 | 9.646B |
| September 30, 2019 | 9.087B |
| June 30, 2019 | 12.91B |
| March 31, 2019 | 11.62B |
| December 31, 2018 | 18.83B |
| September 30, 2018 | 17.24B |
| June 30, 2018 | 13.43B |
| March 31, 2018 | 11.42B |
| December 31, 2017 | 19.99B |
| September 30, 2017 | 16.92B |
| June 30, 2017 | 14.33B |
| March 31, 2017 | 14.56B |
| December 31, 2016 | 17.85B |
| Date | Value |
|---|---|
| September 30, 2016 | 14.37B |
| June 30, 2016 | 20.94B |
| March 31, 2016 | 19.44B |
| December 31, 2015 | 23.29B |
| September 30, 2015 | 20.66B |
| June 30, 2015 | 30.26B |
| March 31, 2015 | 27.71B |
| December 31, 2014 | 36.12B |
| September 30, 2014 | 33.45B |
| June 30, 2014 | 34.05B |
| March 31, 2014 | 33.88B |
| December 31, 2013 | 32.41B |
| September 30, 2013 | 33.68B |
| June 30, 2013 | 33.71B |
| March 31, 2013 | 35.35B |
| December 31, 2012 | 32.40B |
| September 30, 2012 | 22.97B |
| June 30, 2012 | 24.31B |
| March 31, 2012 | 23.97B |
| December 31, 2011 | 26.45B |
| September 30, 2011 | 28.96B |
| June 30, 2011 | 25.48B |
| March 31, 2011 | 24.01B |
| December 31, 2010 | 28.01B |
| September 30, 2010 | 22.46B |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
9.087B
Minimum
Sep 2019
36.12B
Maximum
Sep 2022
18.04B
Average
13.55B
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Moderna Inc | 9.902B |
| Amgen Inc | 9.305B |
| Gilead Sciences Inc | 6.385B |
| Johnson & Johnson | 23.52B |
| Eli Lilly and Co | 2.212B |